Chris and Paul's AI research improves emergency care in Canada

Is most clinical research useless? A nice small piece by Roger Collier looking at the potential shortfalls following on from work by Dr. John Ioannidis. The major things I see we can benefit from as readers or writers of clinical research, or as health practitioners for the betterment of our patients and clients would be some of the following ideas: 1 - It provokes critical reflection by highlighting the issue of potentially useless clinical research, urging researchers to evaluate the real-world impact of our work. 2- It proposes practical improvements and suggests actionable criteria (eg. patient-centred care, transparency, addressing high disease burdens) to enhance the utility of clinical studies. 3 - It identifies systemic issues (a big one) by pointing out flaws in academic and funding systems that incentivise low-value research, encouraging reform discussions. 4 - Lastly it helps spark debate on "usefulness" and challenges the definition of useful research, noting that some studies’ value may only be recognised later, fostering nuanced perspectives. What do you think? Article link: https://lnkd.in/gP5CBwkS

The Australian Academy of Health and Medical Sciences has provided a submission to the Department of Health, Disability and Ageing on the draft National Health and Medical Research Strategy (2026–2036). The submission outlines ten opportunities across five domains to maximise the Strategy’s effectiveness, which are: • Embedding research in the health system • Advancing biomedical discovery science • Strengthening horizon scanning • Building and supporting the workforce • Embracing diversity, equity and inclusion   The Academy also calls for reforms to use unspent Medical Research Future Fund (MRFF) balances to support the Strategy’s implementation, ensuring Australia’s research investment delivers lasting benefits for patients, communities, and the health system. Read more here: https://lnkd.in/gE8jmBQR

This morning I came across an interesting Nature article highlighting the extremely competitive landscape of research funding in Europe and the ripple effects being felt across the research community. Success rates are at an all-time low and so is motivation particularly among early-career academics. One quote resonated with me: “It’s mostly out of your control. And I think that’s sometimes difficult to grapple with in terms of keeping the motivation going.” This challenge is also evident in Australian public health and prevention research, where disproportionate funding and low success rates create significant opportunity costs. Early- to mid-career researchers (EMCRs) in prevention report facing increasing pressures that threaten their well being and the long-term sustainability of Australia’s prevention research workforce. Its important we recognise that research expertise and PhD qualifications are needed and valued beyond academia as well. That’s why I’m proud to work at The Australian Prevention Partnership Centre, where we continue to champion and support systems level prevention research and advocate for stronger accountability and transparency in funding. We recently submitted a response to the draft National Health and Medical Research Strategy consultation emphasising these very priorities (see post below). For those interested, you can read the Nature article here: https://lnkd.in/gaDQfzWH

💡 Did you know? 📚 Case Reports in Women’s Health now hosts a dedicated Resources area, curated by Editor-in-Chief Prof Margaret Rees. https://lnkd.in/dsAK4Cfv This area brings together selected case reports — freely available — to support clinical education worldwide. Cases are organised into: - Rare conditions (e.g., Glanzmann’s thrombasthenia, Fanconi anaemia, Cronkhite-Canada syndrome) - Unusual presentations (e.g., Russell body cervicitis, spontaneous broad ligament rupture) - Therapeutic approaches (e.g., endometriosis shaving technique, ultrasound-guided myelomeningocele drainage) 🔍 Learn more about #EMAS official journals and their contribution to advancing clinical education https://lnkd.in/dz9bPJvM #CRWH #WomensHealth #CaseReports #ClinicalEducation

Not all research involves white coats and laboratories. Annemarie Docherty, a Wellcome Clinical Research Career Development Fellow from The University of Edinburgh, shares how conducting clinical research can benefit public health. Important findings not only improve patient care in hospital, but also shape policy decisions. 🎥 Watch to find out what Annemarie loves about research

Healthcare innovation starts with curiosity — not code. As Annemarie Docherty reminds us, research isn’t confined to the lab. It’s in the quiet rigor of asking better questions, gathering data that shapes both clinical care and public policy, and translating evidence into change. In many ways, clinical research is the engine behind every health system innovation — it tells us what works, for whom, and why. For emerging markets especially, building this bridge between bedside and policy is where transformation begins. #HealthInnovation #ClinicalResearch #PublicHealth #EvidenceBasedCare #HealthcareSystems

Evidence Bridge is a not-for-profit organization dedicated to advancing evidence-informed health policy and practice. Our work brings together cutting-edge research, health economics, and patient values to support better decision-making in healthcare systems. Founded and led by Dr. Yuan Zhang, PhD, a researcher in evidence-based medicine, clinical practice guideline development, patient values and preferences, health economics, and health technology assessment, Evidence Bridge is built on a strong foundation of academic rigor and impact. Dr. Zhang has authored more than 60 peer-reviewed publications, with over 10,000 citations and an h-index of 40+, and holds academic appointments at McMaster University and Brock University in Canada. He has also been recognized among the World’s Top 2% of Scientists by Stanford University and Elsevier. At Evidence Bridge, our mission is to connect research to real-world policy and practice, ensuring that health decisions are guided by the best available evidence and also by the values and preferences of patients and communities.

Darius Lakdawalla, a Cornerstone Research affiliated expert and chief scientific officer of the USC Schaeffer Institute, has been elected to the National Academy of Medicine. Experts elected to the Academy are recognized for their significant contributions to the medical sciences, healthcare, and public health. Professor Lakdawalla was selected as one of one hundred new members for his groundbreaking work in transforming how the economic value of medical innovation is calculated. The Academy recognized Professor Lakdawalla for “using economic insights to reorient health care value assessment around what matters to patients and their families, identifying policies promoting value-based decisions by providers and medical innovators, and illuminating the role of patient behavior in affecting health outcomes.” Read more, here: https://lnkd.in/gk2cN5Qc

There's more to medical research than what happens in the lab. This Medical Research Week, get to know some of the HMRI team members who support and help enable research to happen here in the Hunter and beyond. Dr Shanthi Ramanathan leads our Research Impact & Evaluation team, ensuring our research creates real benefits for community, practice, and policy. Michael Newton drives the creative direction of HMRI, bridges the gap between lab and community, translating complex research into stories that inform and inspire. Dr Patrick Skippen heads our Data Management & Health Informatics team, keeping our research data clean, accurate, and safe so insights reach the community faster. Dr Victoria McCreanor, Head of Health Economics, evaluates the outcomes and costs of medical innovations to guide smarter healthcare investments for all Australians. These are just some of the faces making sure research reaches further, faster. Our teams work across every stage of the research journey, collaborating across disciplines and health settings to turn discoveries into meaningful change for patients and communities both locally and globally. Learn more about our Research Accelerator Services: https://okt.to/Rfe5Wp

💬 Help shape better support for people with endometriosis #FHMRI Researchers are developing an online self-management program to support people living with endometriosis. To make sure the program reflects the needs and experiences of the endometriosis community, the team is forming a Community Advisory Panel and inviting people to get involved. 🌏 If you’re aged 18 or over, live in Australia, and have a diagnosis of endometriosis, you can take part by sharing your experiences and feedback across up to three 1.5-hour workshops. Your voice can help shape a program that makes a real difference. 💛 🔗 Learn more and express your interest: https://lnkd.in/gkpXRN53 #Endometriosis #HealthResearch #FHMRI #FlindersUniversity